Episode 32 - Blunt Cerebrovascular Injury (BCVI) | Trauma ICU Rounds

Dr. Dennis Kim hosts Dr. Walt Biffle to discuss Blunt Cerebrovascular Injury (BCVI). Dr. Biffle shares his early experiences with BCVI, the evolution of screening criteria, and the importance of considering the mechanism of injury. The discussion covers diagnostic imaging modalities like CTA and MRA, grading criteria for BCVI, and treatment options including antithrombotic therapy and stents. They also address specific scenarios such as BCVI in pediatric patients, patients with TBIs or spinal injuries, and the role of vascular surgeons and neurosurgeons in management. The podcast concludes with insights on future research directions and key clinical pearls for listeners.

Outlines

Part 1: Introduction and Genesis of BCVI Research

Part 2: Evolution of Screening Criteria and Advanced Imaging

Part 3: Specific Considerations and Grading

Part 4: Treatment and Multidisciplinary Management

Part 5: Future Research and Conclusion

Sign in to continue reading, translating and more.

Continue

Episode 32 - Blunt Cerebrovascular Injury (BCVI)

Trauma ICU Rounds

Part 1: Introduction and Genesis of BCVI Research

Introduction to Trauma ICU Rounds and Guest Dr. Walt Biffle

The Genesis of BCVI Research and Early Screening

Part 2: Evolution of Screening Criteria and Advanced Imaging

Evolution and Challenges of BCVI Screening Criteria

The Impact of Advanced Imaging on BCVI Screening

Simplifying BCVI Screening and Mechanism of Injury

Physical Exam Findings, Timing of Strokes, and BCVI

Diagnostic Modalities for BCVI: Duplex, MRA, and CTA

Part 3: Specific Considerations and Grading

Pediatric BCVI and Grading Criteria

Prognostic Value of Grading Criteria and Operative Fixes

Part 4: Treatment and Multidisciplinary Management

Antithrombotic Therapy: Heparin vs. Antiplatelet Agents

Multidisciplinary Involvement in BCVI Management

Dual Antiplatelet Therapy and Follow-Up Imaging

Tailoring Follow-Up Imaging and Managing BCVI with Other Injuries

Stents in BCVI Treatment: Benefits and Risks

Part 5: Future Research and Conclusion

Future Research Directions and Duration of Therapy

Final Thoughts and Key Takeaways

Episode 32 - Blunt Cerebrovascular Injury (BCVI)

Trauma ICU Rounds

Part 1: Introduction and Genesis of BCVI Research

00:01Introduction to Trauma ICU Rounds and Guest Dr. Walt Biffle

Introduction to Trauma ICU Rounds and Guest Dr. Walt Biffle

02:29The Genesis of BCVI Research and Early Screening

The Genesis of BCVI Research and Early Screening

Part 2: Evolution of Screening Criteria and Advanced Imaging

05:31Evolution and Challenges of BCVI Screening Criteria

Evolution and Challenges of BCVI Screening Criteria

08:25The Impact of Advanced Imaging on BCVI Screening

The Impact of Advanced Imaging on BCVI Screening

10:50Simplifying BCVI Screening and Mechanism of Injury

Simplifying BCVI Screening and Mechanism of Injury

13:37Physical Exam Findings, Timing of Strokes, and BCVI

Physical Exam Findings, Timing of Strokes, and BCVI

16:30Diagnostic Modalities for BCVI: Duplex, MRA, and CTA

Diagnostic Modalities for BCVI: Duplex, MRA, and CTA

Part 3: Specific Considerations and Grading

19:53Pediatric BCVI and Grading Criteria

Pediatric BCVI and Grading Criteria

22:33Prognostic Value of Grading Criteria and Operative Fixes

Prognostic Value of Grading Criteria and Operative Fixes

Part 4: Treatment and Multidisciplinary Management

25:55Antithrombotic Therapy: Heparin vs. Antiplatelet Agents

Antithrombotic Therapy: Heparin vs. Antiplatelet Agents

29:44Multidisciplinary Involvement in BCVI Management

Multidisciplinary Involvement in BCVI Management

32:33Dual Antiplatelet Therapy and Follow-Up Imaging

Dual Antiplatelet Therapy and Follow-Up Imaging

35:35Tailoring Follow-Up Imaging and Managing BCVI with Other Injuries

Tailoring Follow-Up Imaging and Managing BCVI with Other Injuries

38:50Stents in BCVI Treatment: Benefits and Risks

Stents in BCVI Treatment: Benefits and Risks

Part 5: Future Research and Conclusion

42:25Future Research Directions and Duration of Therapy

Future Research Directions and Duration of Therapy

46:06Final Thoughts and Key Takeaways

Final Thoughts and Key Takeaways